Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Gerard Boyle, MD, is the Medical Director of Pediatric Heart Failure and Transplant Services at Cleveland Clinic. He joined Cleveland Clinic in 2004. He is an Associate Professor of Pediatrics at the Lerner College of Medicine of Case Western Reserve University in Cleveland. Dr. Boyle’s areas of specialization are pediatric heart transplantation and congestive heart failure. He is certified by the American Board of Pediatrics and the sub-specialty Board of Pediatric Cardiology.
Dr. Boyle received his medical degree with Distinction in Research from the State University of New York, College of Medicine, Brooklyn. He completed his residency in pediatrics and a fellowship in pediatric cardiology at Children’s Hospital of Pittsburgh and subsequently advanced to Associate Professor of Pediatrics at The University of Pittsburgh School of Medicine. Dr. Boyle has been a consultant to hospitals in both Pennsylvania and Ohio. He is a diplomat of the National Board of Medical Examiners and is certified in Pediatric Advanced Life Support and Basic Cardiac Life Support[NU1] .
His research has been extensively published in peer-reviewed medical journals. He has been listed as Best Doctor in America (2003-Present) and among America’s Top Cardiologists since 2006. Dr. Boyle is a member of numerous national and international professional societies, including the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, the International Pediatric Transplant Society, the American Society of Transplantation and the International Society for Heart and Lung Transplantation, among others. Regionally, he is a member of the Northern Ohio Pediatric society and serves on the board of trustees of the Ohio Chapter of the American College of Cardiology.
Dr. Boyle is a Founding Board Member of Flying Horse Farms Camp in Mt Gilead, Ohio. The camp is a member of the Association of Hole-in-the-Wall camps, founded by Paul Newman. This association is a family of camps around the world built specifically to serve terminally ill and medically fragile children. The Flying Horse Farms Camp is the first Association camp in the Mid-West. Dr. Boyle served as the first Medical Director of the camp from 2005-2010, during its build and start-up phase. He currently serves as the Chairman of the Medical Advisory Board of the camp.
Pediatric Congestive Heart Failure, Pediatric Heart Transplantation, Pediatric VAD's, Berlin Heart, PLE, PTLD
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/1/2016, Dr. Boyle has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.